Singapore markets close in 5 hours 4 minutes

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

SES - SES Delayed price. Currency in USD
Add to watchlist
2.4900+0.0300 (+1.22%)
As of 11:22AM SGT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.19B
Enterprise value 2.93B
Trailing P/E 13.94
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.66
Price/book (mrq)1.94
Enterprise value/revenue 2.57
Enterprise value/EBITDA 18.77

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 321.78%
S&P500 52-week change 322.23%
52-week high 32.6600
52-week low 31.6600
50-day moving average 32.4138
200-day moving average 32.0384

Share statistics

Avg vol (3-month) 3127.94k
Avg vol (10-day) 389.19k
Shares outstanding 5200M
Implied shares outstanding 61.28B
Float 8426.87M
% held by insiders 18.62%
% held by institutions 10.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.16
Forward annual dividend yield 47.91%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 45.51
Payout ratio 488.76%
Dividend date 3N/A
Ex-dividend date 426 May 2023
Last split factor 22:1
Last split date 330 Jun 2010

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 12.00%
Operating margin (ttm)2.69%

Management effectiveness

Return on assets (ttm)4.90%
Return on equity (ttm)14.68%

Income statement

Revenue (ttm)8.22B
Revenue per share (ttm)10.67
Quarterly revenue growth (yoy)-9.60%
Gross profit (ttm)N/A
EBITDA 923.54M
Net income avi to common (ttm)986.71M
Diluted EPS (ttm)0.1800
Quarterly earnings growth (yoy)-3.30%

Balance sheet

Total cash (mrq)2.19B
Total cash per share (mrq)2.84
Total debt (mrq)339.14M
Total debt/equity (mrq)5.10%
Current ratio (mrq)2.03
Book value per share (mrq)8.57

Cash flow statement

Operating cash flow (ttm)688.49M
Levered free cash flow (ttm)365.73M